Eckert & Ziegler Strahlen- und Medizintechnik AG reaffirms earnings guidance for the year 2022. The forecast for the 2022 financial year published in March remains unaffected. The Executive Board continues to expect sales of around EUR 200 million and a net profit of around EUR 38 million.

The forecast is subject to the assumption that the developments in Ukraine do not result in any major disruptions.